Sign in
4/A

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040268

Options or other derivatives

  • President & CEO acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
GOOD JENNIFER L President & CEO 2022-02-14 Grant or award · Stock Option (right to buy) +275,000 275,000 D: show line 1 in the form
Loading xslF345X03/doc4a.xml…